Prospects of targeted and immune therapies in SCLC-Reference-Cited by-同舟云学术

Prospects of targeted and immune therapies in SCLC

Published:2018-12-28 Issue:2 Volume:19 Page:151-167
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Hendriks Lizza E. L.¹²,Menis Jessica³,Reck Martin⁴

Affiliation:

1. Department of Pulmonary Diseases, GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands

2. Department of Medical Oncology, Gustave Roussy, Institut d’Oncologie Thoracique (IOT), Gustave Roussy, Université Paris-Saclay, Villejuif, France

3. Medical Oncology, University of Padua and Veneto Institute of Oncology IOV – IRCCS, Padua, Italy

4. Airway Research Center North (ARCN), German Center for Lung Research, LungenClinic, Grosshansdorf, Germany

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2019.1559057

Reference139 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

3. Lung Cancer Statistics

4. Global Cancer Incidence and Mortality Rates and Trends—An Update

5. Prognostic Factors for Survival in Extensive Stage Small Cell Lung Cancer (ED-SCLC): The Importance of Smoking History, Socioeconomic and Marital Statuses, and Ethnicity

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China;BMC Cancer;2023-12-01

3. Delta-like ligand 3 in small cell lung cancer: Potential mechanism and treatment progress;Critical Reviews in Oncology/Hematology;2023-11

4. Construction and validation of a prognostic nomogram model for SCLC patients in Shandong Province, China;2023-07-14

5. Analysis of Baseline Serum Lipid Profile for Predicting Clinical Outcomes of Patients with Extensive-Stage Small Cell Lung Cancer;Cancer Management and Research;2023-07